Literature DB >> 16478988

Abnormal expression of REST/NRSF and Myc in neural stem/progenitor cells causes cerebellar tumors by blocking neuronal differentiation.

Xiaohua Su1, Vidya Gopalakrishnan, Duncan Stearns, Kenneth Aldape, Fredrick F Lang, Gregory Fuller, Evan Snyder, Charles G Eberhart, Sadhan Majumder.   

Abstract

Medulloblastoma, one of the most malignant brain tumors in children, is thought to arise from undifferentiated neural stem/progenitor cells (NSCs) present in the external granule layer of the cerebellum. However, the mechanism of tumorigenesis remains unknown for the majority of medulloblastomas. In this study, we found that many human medulloblastomas express significantly elevated levels of both myc oncogenes, regulators of neural progenitor proliferation, and REST/NRSF, a transcriptional repressor of neuronal differentiation genes. Previous studies have shown that neither c-Myc nor REST/NRSF alone could cause tumor formation. To determine whether c-Myc and REST/NRSF act together to cause medulloblastomas, we used a previously established cell line derived from external granule layer stem cells transduced with activated c-myc (NSC-M). These immortalized NSCs were able to differentiate into neurons in vitro. In contrast, when the cells were engineered to express a doxycycline-regulated REST/NRSF transgene (NSC-M-R), they no longer underwent terminal neuronal differentiation in vitro. When injected into intracranial locations in mice, the NSC-M cells did not form tumors either in the cerebellum or in the cerebral cortex. In contrast, the NSC-M-R cells did produce tumors in the cerebellum, the site of human medulloblastoma formation, but not when injected into the cerebral cortex. Furthermore, the NSC-M-R tumors were blocked from terminal neuronal differentiation. In addition, countering REST/NRSF function blocked the tumorigenic potential of NSC-M-R cells. To our knowledge, this is the first study in which abnormal expression of a sequence-specific DNA-binding transcriptional repressor has been shown to contribute directly to brain tumor formation. Our findings indicate that abnormal expression of REST/NRSF and Myc in NSCs causes cerebellum-specific tumors by blocking neuronal differentiation and thus maintaining the "stemness" of these cells. Furthermore, these results suggest that such a mechanism plays a role in the formation of human medulloblastoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16478988      PMCID: PMC1430235          DOI: 10.1128/MCB.26.5.1666-1678.2006

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  69 in total

1.  Constitutive expression of the neuron-restrictive silencer factor (NRSF)/REST in differentiating neurons disrupts neuronal gene expression and causes axon pathfinding errors in vivo.

Authors:  A J Paquette; S E Perez; D J Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

2.  Combinatorial roles of the nuclear receptor corepressor in transcription and development.

Authors:  K Jepsen; O Hermanson; T M Onami; A S Gleiberman; V Lunyak; R J McEvilly; R Kurokawa; V Kumar; F Liu; E Seto; S M Hedrick; G Mandel; C K Glass; D W Rose; M G Rosenfeld
Journal:  Cell       Date:  2000-09-15       Impact factor: 41.582

3.  Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors.

Authors:  A Koch; A Waha; J C Tonn; N Sörensen; F Berthold; M Wolter; J Reifenberger; W Hartmann; W Friedl; G Reifenberger; O D Wiestler; T Pietsch
Journal:  Int J Cancer       Date:  2001-08-01       Impact factor: 7.396

4.  REST and its corepressors mediate plasticity of neuronal gene chromatin throughout neurogenesis.

Authors:  Nurit Ballas; Christopher Grunseich; Diane D Lu; Joan C Speh; Gail Mandel
Journal:  Cell       Date:  2005-05-20       Impact factor: 41.582

5.  A genetic screen for candidate tumor suppressors identifies REST.

Authors:  Thomas F Westbrook; Eric S Martin; Michael R Schlabach; Yumei Leng; Anthony C Liang; Bin Feng; Jean J Zhao; Thomas M Roberts; Gail Mandel; Gregory J Hannon; Ronald A Depinho; Lynda Chin; Stephen J Elledge
Journal:  Cell       Date:  2005-06-17       Impact factor: 41.582

6.  Protein kinase A regulates cholinergic gene expression in PC12 cells: REST4 silences the silencing activity of neuron-restrictive silencer factor/REST.

Authors:  M Shimojo; A J Paquette; D J Anderson; L B Hersh
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

7.  Many human medulloblastoma tumors overexpress repressor element-1 silencing transcription (REST)/neuron-restrictive silencer factor, which can be functionally countered by REST-VP16.

Authors:  Gregory N Fuller; Xiaohua Su; Roger E Price; Zvi R Cohen; Frederick F Lang; Raymond Sawaya; Sadhan Majumder
Journal:  Mol Cancer Ther       Date:  2005-03       Impact factor: 6.261

8.  C-MYC expression in medulloblastoma and its prognostic value.

Authors:  J Herms; I Neidt; B Lüscher; A Sommer; P Schürmann; T Schröder; M Bergmann; B Wilken; S Probst-Cousin; P Hernáiz-Driever; J Behnke; F Hanefeld; T Pietsch; H A Kretzschmar
Journal:  Int J Cancer       Date:  2000-09-20       Impact factor: 7.396

9.  Identification of human brain tumour initiating cells.

Authors:  Sheila K Singh; Cynthia Hawkins; Ian D Clarke; Jeremy A Squire; Jane Bayani; Takuichiro Hide; R Mark Henkelman; Michael D Cusimano; Peter B Dirks
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

Review 10.  The developmental biology of brain tumors.

Authors:  R Wechsler-Reya; M P Scott
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

View more
  74 in total

1.  Eradicating the mediators of neuronal death with a fine-tooth comb.

Authors:  R Suzanne Zukin
Journal:  Sci Signal       Date:  2010-06-08       Impact factor: 8.192

2.  myc maintains embryonic stem cell pluripotency and self-renewal.

Authors:  Natalia V Varlakhanova; Rebecca F Cotterman; Wilhelmine N deVries; Judy Morgan; Leah Rae Donahue; Stephen Murray; Barbara B Knowles; Paul S Knoepfler
Journal:  Differentiation       Date:  2010-05-27       Impact factor: 3.880

3.  Corepressor for element-1-silencing transcription factor preferentially mediates gene networks underlying neural stem cell fate decisions.

Authors:  Joseph J Abrajano; Irfan A Qureshi; Solen Gokhan; Aldrin E Molero; Deyou Zheng; Aviv Bergman; Mark F Mehler
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-07       Impact factor: 11.205

Review 4.  REST and CoREST are transcriptional and epigenetic regulators of seminal neural fate decisions.

Authors:  Irfan A Qureshi; Solen Gokhan; Mark F Mehler
Journal:  Cell Cycle       Date:  2010-11-15       Impact factor: 4.534

5.  Regulation of mGluR1 expression in human melanocytes and melanoma cells.

Authors:  Hwa Jin Lee; Brian A Wall; Janet Wangari-Talbot; Suzie Chen
Journal:  Biochim Biophys Acta       Date:  2012-07-05

6.  Targeting the enhancer of zeste homologue 2 in medulloblastoma.

Authors:  Irina Alimova; Sujatha Venkataraman; Peter Harris; Victor E Marquez; Paul A Northcott; Adrian Dubuc; Michael D Taylor; Nicholas K Foreman; Rajeev Vibhakar
Journal:  Int J Cancer       Date:  2012-07-30       Impact factor: 7.396

7.  Targeted inhibition of cyclic AMP phosphodiesterase-4 promotes brain tumor regression.

Authors:  Patricia Goldhoff; Nicole M Warrington; David D Limbrick; Andrew Hope; B Mark Woerner; Erin Jackson; Arie Perry; David Piwnica-Worms; Joshua B Rubin
Journal:  Clin Cancer Res       Date:  2008-12-01       Impact factor: 12.531

8.  NRSF/REST levels are decreased in cholangiocellular carcinoma but not hepatocellular carcinoma compared with normal liver tissues: A tissue microarray study.

Authors:  Yanlan Yu; Shan Li; Huiyan Zhang; Xuqing Zhang; Deyu Guo; Jiqiang Zhang
Journal:  Oncol Lett       Date:  2018-03-05       Impact factor: 2.967

9.  REST is a novel prognostic factor and therapeutic target for medulloblastoma.

Authors:  Pete Taylor; Jason Fangusaro; Veena Rajaram; Stewart Goldman; Irene B Helenowski; Tobey MacDonald; Martin Hasselblatt; Lars Riedemann; Alvaro Laureano; Laurence Cooper; Vidya Gopalakrishnan
Journal:  Mol Cancer Ther       Date:  2012-07-30       Impact factor: 6.261

Review 10.  Epigenetic gene regulation in stem cells and correlation to cancer.

Authors:  Lesley A Mathews; Francesco Crea; W L Farrar
Journal:  Differentiation       Date:  2009-05-14       Impact factor: 3.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.